Dr. Malin Vedøy Uthaug - Ayahuasca and 5-MeO-DMT Research
Release Date: 07/21/2020
PT 639 - Evelyn Eddy Shoop PMHNP-BC: Lived Experience, Qualitative Data, and the Future of Psychedelic Care
Psychedelics Today
Overview Evelyn Eddy Shoop PMHNP-BC joins Psychedelics Today to share her journey from Division I athlete to psychiatric mental health nurse practitioner and psilocybin research participant. In this conversation, she explains how sports injuries, OCD, and intensive treatment led her into psychiatry and eventually into a psilocybin clinical trial at Yale. Her story weaves together lived experience, clinical training, and a call for more humane systems of care and better qualitative data in psychedelic science. Early Themes: Injury, OCD, and Choosing Psychiatry Early in the episode, Evelyn...
info_outline
PT 638 - Dr Jason Konner - Psychedelic Oncologist
Psychedelics Today
In this episode, Joe Moore sits down with Dr. Jason Konner, a longtime oncologist who recently left his full-time clinical role at to devote himself to the emerging intersection of cancer care and psychedelics. Dr Konner shares how, after more than two decades treating people, he hit a wall. The accumulated grief, constant exposure to death, and intensity of oncology left him deeply , though he didn’t have that language for it at the time. A chance moment in a yoga class, overhearing someone say “ retreat” just before he was scheduled for hernia surgery, became the turning point....
info_outline
PT 637 - Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of Integration
Psychedelics Today
Clinical psychologist Dr. Genesee Herzberg joins Kyle to reflect on two decades in trauma work and 15 years inside the psychedelic ecosystem—from early MAPS conferences to running Sage Integrative Health. She traces how personal psychedelic experiences set her on a path of service, research at CIIS on MDMA-assisted therapy, and hands-on roles with MAPS: Zendo Project harm reduction, adherence rating, and ultimately serving as an MDMA therapist in clinical trials. Today she leads Sage, an integrative clinic (psychotherapy, psychiatry, bodywork, acupuncture, and functional nutrition) focused...
info_outline
PT 636 - Dr. Ros Watts – Building Communities and Connection
Psychedelics Today
Clinical psychologist joins to share insights from her decade of work with and her evolving focus on community-based integration. As the former Clinical Lead for , Dr. Watts witnessed how psychedelic experiences can foster profound feelings of — to self, others, and nature — yet also how that connection can fade without ongoing support. In this conversation, she reflects on what years of research have taught her about connectedness as both a healing mechanism and a human need. She explores how can transform fleeting psychedelic breakthroughs into lasting change, and why community is...
info_outline
PT 635 - Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher
Psychedelics Today
Artist, builder, and podcast host Jennifer Espenscheid joins Joe Moore for a rich conversation on creativity, process, and the spiritual dimensions of making art. Drawing from her South Dakota roots and large-scale works like Luciferia, Jennifer reflects on the blend of grit, intuition, and trust that guides her artistic life. She discusses how psychedelics have served as a tool for clarity and healing rather than direct creation of art, helping her dissolve patterns and reconnect to innate creativity. They explore how events like Burning Man catalyze inspiration, why intention and...
info_outline
PT 634 - Brad Adams - LAMPS
Psychedelics Today
Brad Adams — LAMPS (Los Angeles Psychedelic Society) joins Kyle to trace his path from PhD researcher to community builder. Brad shares how early work in AIDS, Alzheimer’s, gerontology, and cancer research primed him to notice Harbor-UCLA’s psilocybin pilot for stage-4 cancer patients with death anxiety—where the strongest mystical experiences correlated with profound death acceptance. Teaming with Dennis McKenna, he ran an ayahuasca pilot in Peru and presented findings at Psychedelic Science 2017. From there, Brad founded LAMPS: first as research meetups at UCLA, then as a thriving...
info_outline
PT 633 - Dreamshadow - Life and Breath
Psychedelics Today
In this episode, Kyle and Joe sit down with filmmaker Mustapha Khan and Dreamshadow’s Elizabeth & Lenny Gibson to explore Life and Breath—a new documentary immersing viewers in the experience and community of Holotropic Breathwork. We talk about why Mustapha was drawn to Dreamshadow, the film’s cinéma vérité approach that places you “in the room,” and how years of facilitation informed what became both an archival record and a living portrait of transformation. Elizabeth and Lenny reflect on 35+ years of holding space, the role of curiosity over agenda, and why genuine...
info_outline
PT 632 - Megan Portnoy MS - Ontological Design, Psychedelic Spaces, and Integrating Rigor
Psychedelics Today
In this episode, Joe Moore talks with Megan Portnoy, a doctoral candidate in clinical psychology at Antioch University New England, about how can reshape the environments used in psychedelic-assisted therapy. Megan explains how physical space is not just a backdrop but an active participant in the therapeutic process, influencing emotion, cognition, and healing. She recently for her presentation on this topic at . They explore how design principles that foster awe, play, and flexibility can deepen integration and expand what’s possible in clinical settings. The conversation also...
info_outline
PT 631 - Kyle Buller and Joe Moore - Breathwork, Community, Bodywork and more!
Psychedelics Today
Joe and Kyle open with reflections from their first r/psychonaut AMA, then pivot to why they’re building Navigators—our off-social community with book/film clubs, early ad-free episodes, mentorship, and an expanding education library. The core discussion explores touch and bodywork in breathwork and psychedelic contexts: why defaulting to “no touch” and moving slowly matters; informed consent; reading nonverbals; and keeping client agency central. They unpack trauma-informed concepts like the window of tolerance, polyvagal‐adjacent ideas (and critiques), and the ethics of avoiding...
info_outline
PT 630 - TK Wonder and Cipriana Quann
Psychedelics Today
Interviewers: Joe Moore & Anne Philippi Guests: TK Wonder & Cipriana Quann (The Quann Sisters) Recorded: June 18 during MAPS PS 2025 Content note: This episode discusses childhood sexual, physical, and emotional abuse, suicidal ideation, disordered eating, and recovery. Identical twins, writers, and culture-shapers TK Wonder and Cipriana Quann join Joe and Anne for a frank, generous conversation about identity, resilience, and the long arc of healing. Cipriana recounts launching Urban Bush Babes in 2011 to center women of color in beauty and fashion—work that led to a Vogue...
info_outlineIn this episode, Kyle speaks with Imperial College London research assistant and past guest, Dr. Malin Vedøy Uthaug, who just earned her doctorate and published her dissertation on Ayahuasca and 5-MeO-DMT research.
Uthaug discusses how she started working in this field, why Prague is a good place for research, what past research has led to today, how certain factors could predict whether someone would have a more challenging or more mystical experience, how these experiences can treat people with PTSD differently, what dissociation actually means, the differences between vaporized 5-MeO-DMT and intramuscular 5-MeO-DMT injections and how injections typically lead towards better trauma resolution over the "too much too soon" effects of vaporization. They also talk about reactivation (re-experiencing parts of the 5-MeO-DMT experience at a later time) and why it might happen, how it is different from LSD flashbacks, and how expectations, the experience, and the facilitator all come into play.
They discuss her research and dissertation, which consisted of 2 studies on ayahuasca and 3 on 5-MeO-DMT, focusing on if participants saw improvement in convergent thinking and mental health variables (depression, anxiety and stress), and how her placebo-controlled study revealed that those who received the placebo still saw a marked improvement. This leads to a conclusion that often, context may play a larger role than the medicine- feeling safe and being heard in a ceremonial, community-based setting may be the biggest factor towards healing.
Notable Quotes
“Once you make the unconscious conscious, then you can learn from it, and [it’s not] so much about resisting anymore. Carl Jung says, ‘what you resist persists,’ and what I think is happening, especially with PTSD, is that you’re kind of just holding this ball underwater and it’s not allowed to float to the surface.”
“You need to feel safe, you need to experience being heard and seen. Psychedelics do help us remember things that we have repressed, but obviously, [they] also make us very vulnerable and things might come up. And having somebody witness that and validate those feelings that are expressed and shown can be incredibly healing for people.”
“What we can learn is to learn to sit with difficult emotions and to not push them aside. ...I learned that there is comfort in the discomfort. I learned that you can basically figure out so many things about yourself if you just sit with yourself for a moment and you stay in that uncomfortable silence.”
Links
Imperial College London- Centre for Psychedelic Research
Her past Psychedelics Today appearance, 3/21/2018
Save a Toad, Exploit a Chemist t-shirt
About Dr. Malin Vedøy Uthaug
Malin completed her PhD at the department of Neuropsychology and Psychopharmacology, at the faculty of Psychology and Neuroscience at Maastricht University, The Netherlands. As part of her PhD, she investigated the short-term and long-term effects of Ayahuasca and 5-MeO-DMT in naturalistic settings, while simultaneously initiating several other studies on the psychedelic substance Mescaline and the breathing practice known as Holotropic Breathwork (HB). Malin is currently working as a Postdoctoral researcher at The Centre for Psychedelic Research, at Imperial College London, led by Dr. Robin Carhart-Harris. Here she is investigating the effects of 5-MeO-DMT on mental health related variables, brain activity and consciousness together with Dr. Christopher Timmermann. Besides being a researcher, Malin is also an editor for the ‘Journal of Psychedelics Studies’, a board member of the American podcast-show known as Psychedelics Today, and the co-founder of the Norwegian Association for Psychedelic Science (Norsk Forening for Psykedelisk Vitenskap [NFPV]) whose main aim is to educate the general public as well as researchers, and mental health practitioners in Norway about psychedelics.
Support the show
- Patreon
- Leave us a review on Facebook or iTunes
- Share us with your friends
- Join our Facebook group - Psychedelics Today group – Find the others and create community.
